The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
US lung cancer trends by histologic type
Open accessAbstract
BACKGROUND: Lung cancer incidence rates overall are declining in the United States. This study investigated the trends by histologic type and demographic characteristics. METHODS: Surveillance, Epidemiology, and End Results (SEER) program rates of microscopically confirmed lung cancer overall and squamous cell, small cell, adenocarcinoma, large cell, other, and unspecified carcinomas among US whites and blacks diagnosed from 1977 to 2010 and white non‐Hispanics, Asian/Pacific Islanders, and white Hispanics diagnosed from 1992 to 2010 were analyzed by sex and age. RESULTS: Squamous and small cell carcinoma rates declined since the 1990s, although less rapidly among females than males. Adenocarcinoma rates decreased among males and only through 2005, after which they then rose during 2006 to 2010 among every racial/ethnic/sex group; rates for unspecified type declined. Male/female rate ratios declined among whites and blacks more than among other groups. Recent rates among young females were higher than among males for adenocarcinoma among all racial/ethnic groups and for other specified carcinomas among whites. CONCLUSIONS: US lung cancer trends vary by sex, histologic type, racial/ethnic group, and age, reflecting historical cigarette smoking rates, duration, cessation, cigarette composition, and exposure to other carcinogens. Substantial excesses among males have diminished and higher rates of adenocarcinoma among young females have emerged as rates among males declined more rapidly. The recognition of EGFR mutation and ALK rearrangements that occur primarily in adenocarcinomas are the primary basis for the molecular revolution that has transformed lung cancer diagnosis and treatment over the past decade, and these changes have affected recent type‐specific trends. Cancer 2014;120:2883–2892. © 2014 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
The National Lung Screening Trial Research Team (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1102873 · Cited by 11,064
Travis, W. D., Brambilla, E., Noguchi, M., Nicholson, A. G., Geisinger, K. R., Yatabe, Y., Beer, D. G., Powell, C. A., Riely, G. J., Van Schil, P. E., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e318206a221 · Cited by 4,792
Self-citation21st-Century Hazards of Smoking and Benefits of Cessation in the United States
Jha, P., Ramasundarahettige, C., Landsman, V., Rostron, B., Thun, M., Anderson, R. N., McAfee, T., & Peto, R. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211128 · Cited by 1,767 · cited 1×
“cigarettes per day, number of years smoking, and smoking cessation all influence lung cancer risk and may affect histology in different ways.(17,21) However, changing tobacco blends decreased nicotine but increased nitrate and Nnitrosamines,(5) and genetic selection of tobacco plants resulted in deeper inhalation,(17,…”
BackgroundInternational Classification of Diseases for Oncology
Trott, P. A. (1977) · Journal of Clinical Pathology · doi:10.1136/jcp.30.8.782-c · Cited by 1,676
50-Year Trends in Smoking-Related Mortality in the United States
Thun, M. J., Carter, B. D., Feskanich, D., Freedman, N. D., Prentice, R., Lopez, A. D., Hartge, P., & Gapstur, S. M. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1211127 · Cited by 1,177
Courtney, R. (2015) · Drug and Alcohol Review · doi:10.1111/dar.12309 · Cited by 1,168
Selection Criteria for Lung-Cancer Screening
Tammemägi, M. C., Katki, H. A., Hocking, W. G., Church, T. R., Caporaso, N., Kvale, P. A., Chaturvedi, A. K., Silvestri, G. A., Riley, T. L., Commins, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211776 · Cited by 1,029
Self-citationYódice, A., & CHIARE, F. L. (1954) · PubMed · Cited by 836
Devesa, S. S., Bray, F., Vizcaino, A. P., & Parkin, D. M. (2005) · International Journal of Cancer · doi:10.1002/ijc.21183 · Cited by 745
Self-citationNew Pathologic Classification of Lung Cancer: Relevance for Clinical Practice and Clinical Trials
Travis, W. D., Brambilla, E., & Riely, G. J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.9270 · Cited by 599
Self-citationTargeting of Low-Dose CT Screening According to the Risk of Lung-Cancer Death
Kovalchik, S. A., Tammemagi, M., Berg, C. D., Caporaso, N. E., Riley, T. L., Korch, M., Silvestri, G. A., Chaturvedi, A. K., & Katki, H. A. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301851 · Cited by 575
Self-citationLung Cancer in Never Smokers: Clinical Epidemiology and Environmental Risk Factors
Samet, J. M., Avila-Tang, E., Boffetta, P., Hannan, L. M., Olivo-Marston, S., Thun, M. J., & Rudin, C. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0376 · Cited by 566
Effect of cigarette smoking on major histological types of lung cancer: a meta-analysis
Khuder, S. A. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00181-1 · Cited by 522
Cigarette Smoking and Changes in the Histopathology of Lung Cancer
Thun, M. J., Lally, C. A., Calle, E. E., Heath, C. W., Flannery, J. T., & Flanders, W. D. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.21.1580 · Cited by 500
Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies
Thun, M. J., Hannan, L. M., Adams-Campbell, L. L., Boffetta, P., Buring, J. E., Feskanich, D., Flanders, W. D., Jee, S. H., Katanoda, K., Kolonel, L. N., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050185 · Cited by 482
Cancer Incidence and Mortality Trends Among Whites in the United States, 1947–84
(1987) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/79.4.701 · Cited by 450
p40 (ΔNp63) is superior to p63 for the diagnosis of pulmonary squamous cell carcinoma
Bishop, J. A., Teruya-Feldstein, J., Westra, W. H., Pelosi, G., Travis, W. D., & Rekhtman, N. (2012) · Modern Pathology · doi:10.1038/modpathol.2011.173 · Cited by 398
Self-citationHow Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease
Office on Smoking (2010) · University of Michigan Library Repository · Cited by 287
Travis, W. D., Lubin, J., Ries, L., & Devesa, S. (1996) · Cancer · doi:10.1002/(sici)1097-0142(19960615)77:12<2464::aid-cncr8>3.0.co;2-m · Cited by 254
Self-citationTobacco use and cancer: an epidemiologic perspective for geneticists
Thun, M. J., Henley, S. J., & Calle, E. E. (2002) · Oncogene · doi:10.1038/sj.onc.1205807 · Cited by 228
Occupational and Environmental Causes of Lung Cancer
Field, R. W., & Withers, B. L. (2012) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2012.07.001 · Cited by 176
Graphical Presentation of Trends in Rates
Devesa, S. S., Donaldson, J., & Fears, T. (1995) · American Journal of Epidemiology · doi:10.1093/aje/141.4.300 · Cited by 159
Self-citationEffect of Smoking Cessation on Major Histologic Types of Lung Cancer
Khuder, S., & Mutgi, A. B. (2001) · CHEST Journal · doi:10.1378/chest.120.5.1577 · Cited by 143
Epidemiology of Lung Cancer in Women: Risk Factors, Survival, and Screening
Kligerman, S. J., & WHITE, C. S. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.5412 · Cited by 137
Devesa, S. S., Grauman, D., Blot, W. J., & Fraumeni, J. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1040 · Cited by 115
Self-citationPierce, J. P., White, M. M., & Messer, K. S. (2009) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntp014 · Cited by 103
Jemal, A., Travis, W. D., Tarone, R. E., Travis, L. B., & Devesa, S. S. (2003) · International Journal of Cancer · doi:10.1002/ijc.11020 · Cited by 100
Self-citationSpitz, M. R., Wu, X., Wilkinson, A. V., & Wei, Q. (2006) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195149616.003.0033 · Cited by 82
Lung Cancer Screening: Review and Performance Comparison Under Different Risk Scenarios
Tota, J. E., Ramanakumar, A. V., & Franco, E. L. (2013) · Lung · doi:10.1007/s00408-013-9517-x · Cited by 37
An emerging place for lung cancer genomics in 2013.
Daniels, M. G., Bowman, R., Yang, I. A., Govindan, R., & Fong, K. M. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2072-1439.2013.10.06 · Cited by 31
Introduction to control engineering
Burns, R. S., & Burns, R. S. (2001) · Elsevier eBooks · doi:10.1016/b978-075065100-4/50002-4 · Cited by 13
Cited by
The 2015 World Health Organization Classification of Lung Tumors
Travis, W. D., Brambilla, E., Nicholson, A. G., Yatabe, Y., Austin, J. H. M., Beasley, M. B., Chirieac, L. R., Dacic, S., Duhig, E., Flieder, D. B., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000630 · Cited by 4,520
Self-citationThe Effect of Advances in Lung-Cancer Treatment on Population Mortality
Howlader, N., Forjaz, G., Mooradian, M. J., Meza, R., Kong, C. Y., Cronin, K. A., Mariotto, A. B., Lowy, D. R., & Feuer, E. J. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1916623 · Cited by 1,712
Cancer Progress and Priorities: Lung Cancer
Schabath, M. B., & Cote, M. L. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-19-0221 · Cited by 1,160
Small-cell lung cancer: what we know, what we need to know and the path forward
Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.87 · Cited by 904
The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics
Cheng, T.-Y. D., Cramb, S. M., Baade, P. D., Youlden, D. R., Nwogu, C., & Reid, M. E. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.05.021 · Cited by 600
Metadata
- Authors
- Lewis, D. R., Check, D. P., Caporaso, N. E., Travis, W. D., & Devesa, S. S.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2014-08-11
- Volume
- 120
- Issue
- 18
- Pages
- 2883-2892
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1544876451
- Cited by
- 264
- References
- 32
- FWCI
- 10.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.